Examinant per Autoria "Pedro Olive, Carme"
Resultats per pàgina
Opcions d'ordenació
Ítem Accés Obert Bone marrow fibrosis in myelodysplastic syndromes: a prospective evaluation including mutational analysis.(Impact Journals, 2016) Ramos, Fernando; Robledo, Cristina; Izquierdo-García, Francisco Miguel; Suárez-Vilela, Dimas; Benito, Rocío; Fuertes, Marta; Insunza, Andrés; Barragán, Eva; Rey, Mónica del; García-Ruiz de Morales, José María; Tormo, Mar; Salido, Eduardo; Zamora, Lurdes; Pedro Olive, Carme; Sánchez-del-Real, Javier; Díez-Campelo, María; Cañizo, Consuelo del; Sanz, Guillermo F.; Hernández-Rivas, Jesús María; Spanish Group for Myelodysplastic Syndromes (GESMD)
Ítem Accés Obert Clinical Outcomes of 217 Patients with Acute Erythroleukemia According to Treatment Type and Line: A Retrospective Multinational Study(MDPI, 2017) Almeida, Antonio M.; Pedro Olive, Carme; Pleyer, Lisa
Ítem Accés Obert Evaluation of the outcomes of newly diagnosed patients with high-risk myelodysplastic syndrome according to the initial therapeutical strategies chosen in usual clinical practice(Taylor & Francis, 2023) Montoro, Maria Julia; Pomares, Helena; Coll, Rosa; Bernal del Castillo, Teresa; Tormo, Mar; Jiménez, Ana; Brunet, Salut; Casaño, Javier; Oiartzabal, Itziar; Díez-Campelo, María; Ramos, Fernando; Romero, Rafael; Salido-Fiérrez, Eduardo; Pedro Olive, Carme; Bargay, Joan; Muñoz-Novas, Carolina; López, Rocío; Rafel, Montserrat; Valcárcel, David; ERASME study group
Ítem Accés Obert Impact of mutational studies on the diagnosis and the outcome of high-risk myelodysplastic syndromes and secondary acute myeloid leukemia patients treated with 5-azacytidine(Impact Journal, 2018) Cabezón, Marta; Bargay, Joan; Xicoy, Blanca; García, Olga; Borràs, Josep M.; Tormo, Mar; Marcé, Sílvia; Pedro Olive, Carme; Valcárcel, David; Jiménez, Maria-José; Guàrdia, Ramón; Valcárcel, David; Jiménez, Maria-José; Palomo, Laura; Brunet, Salut; Vall-llovera, Ferrán; García, Antonio; Feliu, Evarist; Zamora, Lurdes; CETLAM Group
Ítem Accés Obert Multidimensional assessment of patient condition and mutational analysis in peripheral blood, as tools to improve outcome prediction in myelodysplastic syndromes: A prospective study of the Spanish MDS group(Wiley, 2017) Ramos, Fernando; Robledo, Cristina; Pereira, Arturo; Pedro Olive, Carme; Benito, Rocío; De Paz, Raquel; Rey, Mónica del; Insunza, Andrés; Tormo, Mar; Díez-Campelo, María; Xicoy, Blanca; Salido, Eduardo; Sánchez-del-Real, Javier; Arenillas Rocha, Leonor; Florensa Brichs, Lourdes; Luño, Elisa; Cañizo, Consuelo del; Sanz, Guillermo F.; Hernández-Rivas, Jesús María; Spanish Group for Myelodysplastic Syndromes (GESMD)
Ítem Accés Obert The expression level of BAALC-associated microRNA miR-3151 is an independent prognostic factor in younger patients with cytogenetic intermediate-risk acute myeloid leukemia.(Nature Publishing Group, 2015) Díaz-Beyá, M.; Pedro Olive, Carme; Esteve, J.
Ítem Accés Obert Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification-an approach to classification of patients with t-MDS(Nature Research, 2020) Kuendgen, A.; Calvo Gonzalo, Xavier; Pedro Olive, Carme; Sanz, Guillermo F.
Ítem Accés Obert Trisomy 8, a Cytogenetic Abnormality in Myelodysplastic Syndromes, Is Constitutional or Not?(Public Library of Science, 2015) Saumell, Silvia; Solé Ristol, Francesc; Arenillas Rocha, Leonor; Montoro, Julia; Valcárcel, David; Pedro Olive, Carme; Sanzo, Carmen; Luño, Elisa; Giménez, Teresa; Arnan, Montserrat; Pomares, Helena; De Paz, Raquel; Arrizabalaga, Beatriz; Jerez, Andrés; Martínez, Ana B.; Sánchez-Castro, Judith; Rodríguez-Gambarte, Juan D.; Raya, José M.; Ríos, Eduardo; Rodríguez-Rivera, María; Espinet Solà, Blanca; Florensa Brichs, Lourdes